A PHASE I/II OPEN-LABEL STUDY OF THE SAFETY AND EFFICACY OF EPSTEIN-BARR VIRUS SPECIFIC T-CELL LINES FOR THE TREATMENT OF EBV INFECTION OR EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
- Registry ID
- EBV-TCL-01
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Phase
- PHASE1
- Study type
- INTERVENTIONAL
- Sponsor
- HOPITAL MAISONNEUVE ROSEMONT
- Start date
- 2015-11-17
- Last update
- 2015-09-03
Conditions
- EPSTEIN-BARR VIRUS (EBV) INFECTION
View on source registry